Gliom (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Gliom" in German language version.

Last modified:

Ref.Un. Ref.Website
Global rank German rank
107th place
5th place
2nd place
3rd place
5th place
7th place
1st place
1st place
6,127th place
4,774th place
low place
low place
87th place
6th place
low place
low place
3,170th place
384th place
3,794th place
234th place
292nd place
564th place
low place
low place
low place
8,115th place
267th place
10th place

aerzteblatt.de (Global: 3,794th place; German: 234th place)

dgnc.de (Global: low place; German: low place)

dgnn.de (Global: low place; German: low place)

doi.org (Global: 2nd place; German: 3rd place)

  • Yiwen Jiang, Lene Uhrbom: On the origin of glioma. In: Upsala Journal of Medical Sciences. Band 117, Nr. 2, Mai 2012, ISSN 0300-9734, S. 113–121, doi:10.3109/03009734.2012.658976, PMID 22348397, PMC 3339543 (freier Volltext) – (englisch, ujms.net [abgerufen am 31. Januar 2021]).
  • Quinn T. Ostrom, Gino Cioffi, Haley Gittleman et al.: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. In: Neuro-Oncology. Band 21, Supplement_5, 1. November 2019, ISSN 1522-8517, S. v1–v100, doi:10.1093/neuonc/noz150, PMID 31675094, PMC 6823730 (freier Volltext) – (englisch).
  • Thomas Schneider, Christian Mawrin, Cordula Scherlach, Martin Skalej, Raimund Firsching: Gliomas in Adults. In: Deutsches Aerzteblatt Online. 12. November 2010, ISSN 1866-0452, doi:10.3238/arztebl.2010.0799, PMID 21124703, PMC 2994146 (freier Volltext) – (aerzteblatt.de [abgerufen am 31. Januar 2021]).
  • David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree: The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. In: Neuro-Oncology. Band 23, Nr. 8, 2. August 2021, ISSN 1522-8517, S. 1231–1251, doi:10.1093/neuonc/noab106, PMID 34185076, PMC 8328013 (freier Volltext) – (oup.com [abgerufen am 6. Oktober 2021]).
  • Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer et al.: Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. In: Neuro-Oncology. Band 25, Nr. 1, 5. Januar 2023, ISSN 1522-8517, S. 4–25, doi:10.1093/neuonc/noac207, PMID 36239925, PMC 9825337 (freier Volltext).
  • Serena Ammendola, Giuseppe Broggi, Valeria Barresi: IDH-mutant diffuse gliomas: Tips and tricks in the era of genomic tumor classification. In: Histology and Histopathology. Band 38, Nr. 07, 2023, ISSN 0213-3911, S. 739–753, doi:10.14670/HH-18-582.
  • David.E. Reuss: Updates on the WHO diagnosis of IDH-mutant glioma. In: Journal of Neuro-Oncology. Band 162, Nr. 3, Mai 2023, ISSN 0167-594X, S. 461–469, doi:10.1007/s11060-023-04250-5, PMID 36717507, PMC 10227121 (freier Volltext).
  • Rouzbeh Banan, Damian Stichel, Anja Bleck et al.: Infratentorial IDH-mutant astrocytoma is a distinct subtype. In: Acta Neuropathologica. Band 140, Nr. 4, Oktober 2020, ISSN 0001-6322, S. 569–581, doi:10.1007/s00401-020-02194-y.
  • Abigail K. Suwala, Damian Stichel, Daniel Schrimpf et al.: Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis. In: Acta Neuropathologica. Band 141, Nr. 1, Januar 2021, ISSN 0001-6322, S. 85–100, doi:10.1007/s00401-020-02243-6, PMID 33216206, PMC 7785563 (freier Volltext).
  • Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer et al.: Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. In: Neuro-Oncology. Band 25, Nr. 1, 5. Januar 2023, ISSN 1522-8517, S. 4–25, doi:10.1093/neuonc/noac207, PMID 36239925, PMC 9825337 (freier Volltext).
  • Serena Ammendola, Giuseppe Broggi, Valeria Barresi: IDH-mutant diffuse gliomas: Tips and tricks in the era of genomic tumor classification. In: Histology and Histopathology. Band 38, Nr. 07, 2023, ISSN 0213-3911, S. 739–753, doi:10.14670/HH-18-582.
  • Abigail K. Suwala, Marius Felix, Dennis Friedel et al.: Oligosarcomas, IDH-mutant are distinct and aggressive. In: Acta Neuropathologica. Band 143, Nr. 2, Februar 2022, ISSN 0001-6322, S. 263–281, doi:10.1007/s00401-021-02395-z, PMID 34967922, PMC 8742817 (freier Volltext).
  • Sanjay Shete, Fay J Hosking, Lindsay B Robertson et al.: Genome-wide association study identifies five susceptibility loci for glioma. In: Nature Genetics. Band 41, Nr. 8, August 2009, ISSN 1061-4036, S. 899–904, doi:10.1038/ng.407, PMID 19578367, PMC 4501476 (freier Volltext).
  • Margaret Wrensch, Robert B Jenkins, Jeffrey S Chang et al.: Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. In: Nature Genetics. Band 41, Nr. 8, August 2009, ISSN 1061-4036, S. 905–908, doi:10.1038/ng.408, PMID 19578366, PMC 2923561 (freier Volltext).

fu-berlin.de (Global: 3,170th place; German: 384th place)

diss.fu-berlin.de

iarc.fr (Global: 6,127th place; German: 4,774th place)

krebsgesellschaft.de (Global: low place; German: 8,115th place)

nih.gov (Global: 5th place; German: 7th place)

ncbi.nlm.nih.gov

oup.com (Global: 292nd place; German: 564th place)

academic.oup.com

  • David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree: The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. In: Neuro-Oncology. Band 23, Nr. 8, 2. August 2021, ISSN 1522-8517, S. 1231–1251, doi:10.1093/neuonc/noab106, PMID 34185076, PMC 8328013 (freier Volltext) – (oup.com [abgerufen am 6. Oktober 2021]).

spiegel.de (Global: 87th place; German: 6th place)

sueddeutsche.de (Global: 267th place; German: 10th place)

ujms.net (Global: low place; German: low place)

web.archive.org (Global: 1st place; German: 1st place)

zdb-katalog.de (Global: 107th place; German: 5th place)

  • Yiwen Jiang, Lene Uhrbom: On the origin of glioma. In: Upsala Journal of Medical Sciences. Band 117, Nr. 2, Mai 2012, ISSN 0300-9734, S. 113–121, doi:10.3109/03009734.2012.658976, PMID 22348397, PMC 3339543 (freier Volltext) – (englisch, ujms.net [abgerufen am 31. Januar 2021]).
  • Quinn T. Ostrom, Gino Cioffi, Haley Gittleman et al.: CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. In: Neuro-Oncology. Band 21, Supplement_5, 1. November 2019, ISSN 1522-8517, S. v1–v100, doi:10.1093/neuonc/noz150, PMID 31675094, PMC 6823730 (freier Volltext) – (englisch).
  • Thomas Schneider, Christian Mawrin, Cordula Scherlach, Martin Skalej, Raimund Firsching: Gliomas in Adults. In: Deutsches Aerzteblatt Online. 12. November 2010, ISSN 1866-0452, doi:10.3238/arztebl.2010.0799, PMID 21124703, PMC 2994146 (freier Volltext) – (aerzteblatt.de [abgerufen am 31. Januar 2021]).
  • David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree: The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. In: Neuro-Oncology. Band 23, Nr. 8, 2. August 2021, ISSN 1522-8517, S. 1231–1251, doi:10.1093/neuonc/noab106, PMID 34185076, PMC 8328013 (freier Volltext) – (oup.com [abgerufen am 6. Oktober 2021]).
  • Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer et al.: Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. In: Neuro-Oncology. Band 25, Nr. 1, 5. Januar 2023, ISSN 1522-8517, S. 4–25, doi:10.1093/neuonc/noac207, PMID 36239925, PMC 9825337 (freier Volltext).
  • Serena Ammendola, Giuseppe Broggi, Valeria Barresi: IDH-mutant diffuse gliomas: Tips and tricks in the era of genomic tumor classification. In: Histology and Histopathology. Band 38, Nr. 07, 2023, ISSN 0213-3911, S. 739–753, doi:10.14670/HH-18-582.
  • David.E. Reuss: Updates on the WHO diagnosis of IDH-mutant glioma. In: Journal of Neuro-Oncology. Band 162, Nr. 3, Mai 2023, ISSN 0167-594X, S. 461–469, doi:10.1007/s11060-023-04250-5, PMID 36717507, PMC 10227121 (freier Volltext).
  • Rouzbeh Banan, Damian Stichel, Anja Bleck et al.: Infratentorial IDH-mutant astrocytoma is a distinct subtype. In: Acta Neuropathologica. Band 140, Nr. 4, Oktober 2020, ISSN 0001-6322, S. 569–581, doi:10.1007/s00401-020-02194-y.
  • Abigail K. Suwala, Damian Stichel, Daniel Schrimpf et al.: Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis. In: Acta Neuropathologica. Band 141, Nr. 1, Januar 2021, ISSN 0001-6322, S. 85–100, doi:10.1007/s00401-020-02243-6, PMID 33216206, PMC 7785563 (freier Volltext).
  • Julie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer et al.: Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. In: Neuro-Oncology. Band 25, Nr. 1, 5. Januar 2023, ISSN 1522-8517, S. 4–25, doi:10.1093/neuonc/noac207, PMID 36239925, PMC 9825337 (freier Volltext).
  • Serena Ammendola, Giuseppe Broggi, Valeria Barresi: IDH-mutant diffuse gliomas: Tips and tricks in the era of genomic tumor classification. In: Histology and Histopathology. Band 38, Nr. 07, 2023, ISSN 0213-3911, S. 739–753, doi:10.14670/HH-18-582.
  • Abigail K. Suwala, Marius Felix, Dennis Friedel et al.: Oligosarcomas, IDH-mutant are distinct and aggressive. In: Acta Neuropathologica. Band 143, Nr. 2, Februar 2022, ISSN 0001-6322, S. 263–281, doi:10.1007/s00401-021-02395-z, PMID 34967922, PMC 8742817 (freier Volltext).
  • Sanjay Shete, Fay J Hosking, Lindsay B Robertson et al.: Genome-wide association study identifies five susceptibility loci for glioma. In: Nature Genetics. Band 41, Nr. 8, August 2009, ISSN 1061-4036, S. 899–904, doi:10.1038/ng.407, PMID 19578367, PMC 4501476 (freier Volltext).
  • Margaret Wrensch, Robert B Jenkins, Jeffrey S Chang et al.: Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. In: Nature Genetics. Band 41, Nr. 8, August 2009, ISSN 1061-4036, S. 905–908, doi:10.1038/ng.408, PMID 19578366, PMC 2923561 (freier Volltext).